Trial intelligence / Profile preview

Molecular effects of 5% dexpanthenol ointment on wound healing in skin biopsies

2008-002069-30Phase 4Completed

Sponsor
Bayer
Start
Sep 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in cutaneous wound comparing 5% dexpanthenol ointment with Placebo ointment (2 arms). Primary endpoint: Primary: Gene expression changes in dermal fibroblasts and keratinocytes. Started Sep 2008; status: completed.

02

Drugs

dexpanthenol
03

Conditions

cutaneous wound

Beyond the preview

Go deeper on 2008-002069-30.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-002069-30.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call